UCBJF
UCB SA NPV by UCB S.A. (UCBJF)
$70
About UCB SA NPV by UCB S.A. (UCBJF)
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$209.66
52 Week Low
$128.50
Market cap
28.6B
Dividend yield
0.96%
Volume
--
Avg. volume
90
P/E ratio
24.84
UCB SA NPV by UCB S.A. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$209.66
52 Week Low
$128.50
Market cap
28.6B
Dividend yield
0.96%
Volume
--
Avg. volume
90
P/E ratio
24.84